SLI-F06

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSLI-F06
Drug Alias NameFibromodulin derived peptideF06-C40SLI-F06
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCollagen modulators
TargetsCollagen
Therapy Area/IndicationsWounds and InjuriesCicatrix
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesScarless Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesScarless Laboratories Inc
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesCicatrix
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A